Resistant bipolar disorder treated with tamoxifen
L. Matabosch +4 more
openaire +1 more source
Genetic and epigenetic contribution to tamoxifen resistance in breast cancer, concepts to drive therapeutic strategies. [PDF]
Jahangiri R.
europepmc +1 more source
circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells. [PDF]
Li Z +12 more
europepmc +1 more source
Hsa_circ_0062522 affects the progression and tamoxifen resistance of estrogen receptor-positive breast cancer by targeting miR-3163. [PDF]
Bian Y, Ma Y, Xu Y, Mao J, Huang L.
europepmc +1 more source
Dual action of pyrimidine derivatives: Targeting tamoxifen resistance in breast cancer. [PDF]
Yuan J +13 more
europepmc +1 more source
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer. [PDF]
Jiang C +9 more
europepmc +1 more source
Synergistic Combination of Tamoxifen-Tetraphenylethylene Co-Assembled Micelles and Orlistat-Induced Lipid Droplet Inhibition to Overcome Tamoxifen Resistance. [PDF]
Park JY, Lee J, Kim YY, Lee S, Kim Y.
europepmc +1 more source
SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer. [PDF]
Tsoi H +7 more
europepmc +1 more source
In Silico Analysis Reveals MDM2 as a Potential Target of Ursolic Acid for Overcoming Tamoxifen Resistance in Breast Cancer. [PDF]
Jati YS +3 more
europepmc +1 more source
17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark. [PDF]
Collin LJ +15 more
europepmc +1 more source

